These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 15862964)

  • 1. Role of steroid hormones and prolactin in canine mammary cancer.
    Queiroga FL; Pérez-Alenza MD; Silvan G; Peña L; Lopes C; Illera JC
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):181-7. PubMed ID: 15862964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and Tissue Steroid Hormone Levels in Canine Mammary Tumours: Clinical and Prognostic Implications.
    Queiroga FL; Pérez-Alenza D; González-Gil A; Silván G; Peña L; Illera JC
    Reprod Domest Anim; 2015 Oct; 50(5):858-65. PubMed ID: 26332137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroids and receptors in canine mammary cancer.
    Illera JC; Pérez-Alenza MD; Nieto A; Jiménez MA; Silvan G; Dunner S; Peña L
    Steroids; 2006 Jul; 71(7):541-8. PubMed ID: 16631217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between GH/IGF-I axis and steroid hormones (progesterone, 17beta-estradiol) in canine mammary tumours.
    Queiroga FL; Pérez-Alenza MD; Silvan G; Peña L; Lopes CS; Illera JC
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):76-82. PubMed ID: 18367392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive correlation of steroid hormones and EGF in canine mammary cancer.
    Queiroga FL; Pérez-Alenza D; Silvan G; Peña L; Illera JC
    J Steroid Biochem Mol Biol; 2009 May; 115(1-2):9-13. PubMed ID: 19429455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin binding in benign and malignant mammary tissue of female dogs.
    Rutteman GR; Willekes-Koolschijn N; Bevers MM; Van der Gugten AA; Misdorp W
    Anticancer Res; 1986; 6(4):829-35. PubMed ID: 3019223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.
    Spoerri M; Guscetti F; Hartnack S; Boos A; Oei C; Balogh O; Nowaczyk RM; Michel E; Reichler IM; Kowalewski MP
    BMC Vet Res; 2015 Sep; 11():235. PubMed ID: 26370564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal background of canine and feline mammary tumours.
    Rutteman GR; Misdorp W
    J Reprod Fertil Suppl; 1993; 47():483-7. PubMed ID: 8229967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid hormone profile of canine inflammatory mammary carcinoma: a preliminary study.
    Peña L; Silván G; Pérez-Alenza MD; Nieto A; Illera JC
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):211-6. PubMed ID: 12711005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormones and mammary tumour disease in the female dog: an update.
    Rutteman GR
    In Vivo; 1990; 4(1):33-40. PubMed ID: 2103839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
    Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E
    J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Cox-1 and Cox-2 in canine mammary tumours.
    Queiroga FL; Alves A; Pires I; Lopes C
    J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and significance of PTEN in canine mammary gland tumours.
    Qiu C; Lin D; Wang J; Wang L
    Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
    Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
    Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anterior pituitary function in female dogs with mammary tumors: II. Prolactin.
    Rutteman GR; Bevers MM; Misdorp W; Van den Brom WE
    Anticancer Res; 1989; 9(1):241-5. PubMed ID: 2495756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of P-glycoprotein (clone C494) in canine mammary gland tumours.
    Petterino C; Rossetti E; Bertoncello D; Martini M; Zappulli V; Bargelloni L; Castagnaro M
    J Vet Med A Physiol Pathol Clin Med; 2006 May; 53(4):174-8. PubMed ID: 16629950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormones and mammary tumors in the bitch: a review].
    Rutteman GR
    Tijdschr Diergeneeskd; 1992 Feb; 117(3):71-7, 81. PubMed ID: 1736405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours.
    Queiroga FL; Pérez-Alenza MD; González Gil A; Silvan G; Peña L; Illera JC
    Vet Rec; 2014 Oct; 175(16):403. PubMed ID: 25096592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum neopterin, sialic acid and nitric oxide levels in dogs with malignant mammary tumours.
    Tascene N; Kısmalı G; Vural S; Karagul H; Sel T
    Vet Comp Oncol; 2012 Jun; 10(2):155-9. PubMed ID: 22235796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of VEGF-C expression in canine mammary tumours.
    Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
    Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.